Article Information
History
- November 1, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Maximilian Scherer1,2,
- Luka Milosevic1,2,
- Idil Cebi1,3,
- Patrick Bookjans1,
- Bastian Brunett1,
- Robert Guggenberger1,
- Daniel Weiss3 and
- Alireza Gharabaghi1,4,5,*
- 1Institute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, 72076 Tübingen, Germany
- 2Clinical and Computational Neuroscience, Krembil Research Institute, University Health Network, M5T 2S8 11 Toronto, Canada
- 3Center for Neurology, Department for Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany
- 4Center for Bionic Intelligence Tübingen Stuttgart (BITS), 72076 Tübingen, Germany
- 5German Center for Mental Health (DZPG), 72076 Tübingen, Germany
- ↵*Corresponding author: Prof. Alireza Gharabaghi. Address: Institute for Neuromodulation and Neurotechnology, University Hospital Tübingen, Otfried-Müller-Str. 45, 72076 Tübingen, Germany. Email: alireza.gharabaghi{at}uni-tuebingen.de
Posted November 01, 2023.
Better therapeutic efficiency of omnidirectional than directional subthalamic deep brain stimulation in Parkinson’s disease
